Kohl's represents good value for patient investors, says RW Baird Baird believes Kohl's represents good value for patient investors citing low expectations and several credible initiatives that are poised to drive comp improvement in the second half of the year. Shares are Outperform rated with a $63 price target.
News For KSS From The Last 14 Days
Check below for free stories on KSS the last two weeks.
Kohl's price target raised to $68 from $60 at Stifel Stifel increased its price target on Kohl's as the firm thinks the company's new chief customer officer will improve its marketing and sales efforts. Stifel believes that the these improvements could enable the company to generate higher than expected profits. It keeps a Buy rating on the shares.